|
|
|
40
|
0531V
|
IMURAN 50MG TAB (ASG/STO) AZATHIOPRINE
|
AZATHIOPRINE
|
IMURAN
|
100'S
|
C
|
174.27
|
1.74
|
TABLET
|
0
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0621C
|
PURINETHOL 50MG TAB (ASG/STO) MERCAPTOPURINE
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
A
|
104.38
|
4.18
|
TABLET
|
60
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0621C
|
PURINETHOL 50MG TAB (ASG) MERCAPTOP (C)
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
C
|
107.51
|
4.3004
|
TAB
|
60
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
1171V
|
ALDOMET 250MG TAB (ASG/STO) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
5.44
|
0.18
|
TABLET
|
180
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1171V
|
ALDOMET 250MG TAB (ASG) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
11.63
|
0.3878
|
TAB
|
180
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
|
40
|
1172K
|
ALDOMET 500MG TAB (ASG/STO) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
8.83
|
0.29
|
TABLET
|
180
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1172K
|
ALDOMET 500MG TAB (ASG) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
19.03
|
0.6343
|
TAB
|
180
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
|
41
|
2791D
|
OVESTIN 1MG VAG CR (ASG) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15G
|
A
|
42
|
41.9981
|
TUBE
|
1
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
Vaginal
|
6
|
ESTROGENS
|
|
|
|
|
41
|
27921
|
OVESTIN 0.5MG OV (ASG) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15'S
|
A
|
41.9981
|
41.9981
|
PACK
|
1
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
VAGINAL
|
6
|
ESTROGENS
|
|
|
|
|
40
|
3571ZV
|
ZYLOPRIM 100MG TAB (ASG/STO) ALLOPURINOL
|
ALLOPURINOL
|
ZYLOPRIM
|
50'S
|
C
|
27.18
|
0.54
|
TABLET
|
0
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
4040
|
URICOSURIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
3571ZV
|
ZYLOPRIM 100MG TAB (ASG) ALLOPURINOL (C)
|
ALLOPURINOL
|
ZYLOPRIM
|
50'S
|
C
|
27.43
|
0.5486
|
TAB
|
180
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
4040
|
URICOSURIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
URICOSURIC AGENTS
|
|
|
|
|
41
|
5083D
|
SOSTENON 250MG/ML INJ (ASG) TESTOSTERONE (BQ)
|
TESTOSTERONE
|
SOSTENON
|
250MG PFS
|
BQ
|
34.17
|
34.1693
|
PFS
|
4
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
6808
|
ANDROGENS
|
2024-04-01
|
2026-03-31
|
|
IM
|
6
|
ANDROGENS
|
|
|
|
|
40
|
6302AQ
|
NIMBEX 2MG/ML INJ (ASG/STO) CISATRACURIUM
|
CISATRACURIUM
|
NIMBEX
|
5X5ML
|
BQ
|
114.17
|
22.83
|
INJECTION
|
0
|
VIAL
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
6302AQ
|
NIMBEX 2MG/ML INJ (ASG) CISATRACURI (BQ)
|
CISATRACURIUM
|
NIMBEX
|
5X5ML
|
BQ
|
114.17
|
22.8339
|
VIAL
|
0
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
41
|
66311
|
DIPRIVAN 10MG/ML INJ (ASG) PROPOFOL (C)
|
PROPOFOL
|
DIPRIVAN
|
5X20ML
|
C
|
73.91
|
14.7822
|
AMP
|
30
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
2804
|
GENERAL ANESTHETICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
GENERAL ANESTHETICS
|
|